Expertise in
2
conditions

Danielle R. Camisasca

ES, BR 
Expertise in
2
conditions
ES, BR 

Overview

Danielle Camisasca practices practicing medicine in Brazil.

Ms. Camisasca is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Leukoplakia, Lichen Planus, Oral Squamous Cell Carcinoma, and Cutaneous T-Cell Lymphoma (CTCL).

She is actively involved in clinical research, co-authoring 16 peer reviewed articles.

Gender

Female

Locations

ES, Brazil
Other Locations
Vitoria, ES, Brazil
Niteroi, SC, Brazil
Niteroi, RJ, Brazil

Frequently Asked Questions about Danielle R. Camisasca

Is Danielle R. Camisasca a top-rated expert for Leukoplakia?

MediFind is an objective health platform that identifies experts based on real-world data. Danielle R. Camisasca is classified as an Advanced expert for Leukoplakia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Danielle R. Camisasca participate in research or clinical trials?

Yes. Danielle R. Camisasca has published 16 articles and abstracts on conditions like Leukoplakia. You can view a list of Danielle R. Camisasca's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Camisasca's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile